Multidrug-resistant tuberculosis in children: Are the same therapy options available worldwide?-Reference-Cited by-同舟云学术

Multidrug-resistant tuberculosis in children: Are the same therapy options available worldwide?

Published:2023-05 Issue: Volume:130 Page:S16-S19
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Buonsenso Danilo,Autore Giovanni^ORCID,Cusenza Francesca,Passadore Lucrezia,Bonanno Francesca,Esposito Susanna^ORCID

Funder

QIAGEN

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Treatment options for children with multi-drug resistant tuberculosis;Bossù;Expert Rev Clin Pharmacol,2023

2. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: results from a large global cohort;Koirala;Pulmonology,2021

3. World Health Organization. Global tuberculosis report 2022, https://www.who.int/teams/global-tuberculosis-programme/tb-reports; 2022 [accessed25 January 2022].

4. The global burden of tuberculosis mortality in children: a mathematical modelling study;Dodd;Lancet Glob Health,2017

5. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study;Dodd;Lancet Infect Dis,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability of clofazimine capsules in children and adolescents with rifampicin-resistant TB;The International Journal of Tuberculosis and Lung Disease;2024-05-01

2. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management;Journal of Pharmaceutical Analysis;2024-01

3. World Tuberculosis Day 2023 theme “Yes! We Can End TB!”;International Journal of Infectious Diseases;2023-05